Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Современные представления о биопсии сторожевых лимфоузлов при раке молочной железы: обзор. / Кострыгин, Александр Константинович; Блинова, Ксения Александровна; Алексеев, В.В.; Фролова, Д.Е.; Суворов, В.А.; Золкина, М.А.; Гутова, Д.В.; Ионов, К.А.; Антропова, В.В.; Мишина, Ирина Евгеньевна.
в: СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ, Том 24, № 4, 01.10.2025, стр. 112-121.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Современные представления о биопсии сторожевых лимфоузлов при раке молочной железы: обзор
AU - Кострыгин, Александр Константинович
AU - Блинова, Ксения Александровна
AU - Алексеев, В.В.
AU - Фролова, Д.Е.
AU - Суворов, В.А.
AU - Золкина, М.А.
AU - Гутова, Д.В.
AU - Ионов, К.А.
AU - Антропова, В.В.
AU - Мишина, Ирина Евгеньевна
PY - 2025/10/1
Y1 - 2025/10/1
N2 - Objective: to systematically analyze the data available in the modern literature on sentinel lymph node biopsy in breast cancer in various clinical situations. Material and Methods. The search was conducted in the Web of science, PubMed, scopus, Google scholar databases. A total of 213 sources devoted to sentinel lymph node biopsy in breast cancer were analyzed, of which 48 were included in the review. Results. Sentinel lymph node biopsy has been established as a standard procedure in early stages of breast cancer, demonstrating efficacy and safety in small tumors, intact lymph nodes and micrometastases. Currently, there is a clear trend toward expanding sentinel lymph node biopsy indications into more complex cases, including changes in lymph node status after neoadjuvant chemotherapy, multicentric cancer, and recurrent breast cancer. Studies are underway to evaluate the safety of sentinel lymph node biopsy during pregnancy, opening up new perspectives for the treatment of this vulnerable group of patients. Expanding the indications for sentinel lymph node biopsy will help avoid radical lymphadenectomy and its associated complications, such as postmastectomy syndrome. this, in turn, will significantly improve the quality of life of cancer patients by reducing postoperative morbidity and accelerating rehabilitation. Conclusion. Further study and implementation of expanded indications for sentinel lymph node biopsy is a promising direction in modern oncology aimed at optimizing treatment and maintaining the quality of life of patients.
AB - Objective: to systematically analyze the data available in the modern literature on sentinel lymph node biopsy in breast cancer in various clinical situations. Material and Methods. The search was conducted in the Web of science, PubMed, scopus, Google scholar databases. A total of 213 sources devoted to sentinel lymph node biopsy in breast cancer were analyzed, of which 48 were included in the review. Results. Sentinel lymph node biopsy has been established as a standard procedure in early stages of breast cancer, demonstrating efficacy and safety in small tumors, intact lymph nodes and micrometastases. Currently, there is a clear trend toward expanding sentinel lymph node biopsy indications into more complex cases, including changes in lymph node status after neoadjuvant chemotherapy, multicentric cancer, and recurrent breast cancer. Studies are underway to evaluate the safety of sentinel lymph node biopsy during pregnancy, opening up new perspectives for the treatment of this vulnerable group of patients. Expanding the indications for sentinel lymph node biopsy will help avoid radical lymphadenectomy and its associated complications, such as postmastectomy syndrome. this, in turn, will significantly improve the quality of life of cancer patients by reducing postoperative morbidity and accelerating rehabilitation. Conclusion. Further study and implementation of expanded indications for sentinel lymph node biopsy is a promising direction in modern oncology aimed at optimizing treatment and maintaining the quality of life of patients.
UR - https://www.mendeley.com/catalogue/0e089e3a-8bff-3516-bedd-e0b021c31013/
U2 - 10.21294/1814-4861-2025-24-4-112-121
DO - 10.21294/1814-4861-2025-24-4-112-121
M3 - статья
VL - 24
SP - 112
EP - 121
JO - СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ
JF - СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ
SN - 1814-4861
IS - 4
ER -
ID: 143355690